These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. Guyon A; Kussrow A; Olmsted IR; Sandoz G; Bornhop DJ; Nahon JL J Neurosci; 2013 Jul; 33(28):11643-54. PubMed ID: 23843532 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Li X; Risbrough VB; Cates-Gatto C; Kaczanowska K; Finn MG; Roberts AJ; Markou A Neuropharmacology; 2013 Jul; 70():156-67. PubMed ID: 23376712 [TBL] [Abstract][Full Text] [Related]
27. Blockade of the GABAB receptor suppressed alcohol self-administration in rats: an effect similar to that produced by GABAB receptor activation. Maccioni P; Lorrai I; Carai MAM; Gessa GL; Colombo G Behav Pharmacol; 2022 Feb; 33(1):51-60. PubMed ID: 34954712 [TBL] [Abstract][Full Text] [Related]
28. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038 [TBL] [Abstract][Full Text] [Related]
29. Moderation of baclofen response by a GABA Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397 [TBL] [Abstract][Full Text] [Related]
30. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. Leggio L; Garbutt JC; Addolorato G CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):33-44. PubMed ID: 20201813 [TBL] [Abstract][Full Text] [Related]
33. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600 [TBL] [Abstract][Full Text] [Related]
34. Microinjection of baclofen and CGP7930 into the ventral tegmental area suppresses alcohol self-administration in alcohol-preferring rats. Maccioni P; Lorrai I; Contini A; Leite-Morris K; Colombo G Neuropharmacology; 2018 Jul; 136(Pt A):146-158. PubMed ID: 29050951 [TBL] [Abstract][Full Text] [Related]
35. 6-Aryl-quinazolines as novel GABA Huszár J; Petró JL; Hadady Z; Bobok AÁ; Sághy K; Halász AS; Hornyánszky G; Román V; Greiner I; Éles J Bioorg Med Chem Lett; 2022 Jul; 67():128714. PubMed ID: 35367591 [TBL] [Abstract][Full Text] [Related]
36. KK-92A, a novel GABA Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542 [TBL] [Abstract][Full Text] [Related]
37. [Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4]. Guyon A Med Sci (Paris); 2014 Jan; 30(1):9-12. PubMed ID: 24472448 [No Abstract] [Full Text] [Related]
38. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits. Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734 [TBL] [Abstract][Full Text] [Related]